Samsung Biologics Hosts Supplier ESG Day
Samsung Biologics (KRX: 207940.KS) has recently held its second Supplier ESG Day, focusing on sustainable management within the biopharmaceutical industry. This initiative aims to foster collaboration among suppliers, expanding awareness and practical actions toward environmental, social, and governance (ESG) objectives.
Event Overview and Participation
The event was conducted virtually, allowing participation from over 82 suppliers, including notable names like Merck, Cytiva, Thermo Fisher, and Sartorius. By embracing an inclusive approach, Samsung Biologics emphasizes the importance of collective responsibility in creating sustainable value chains in healthcare.
Leadership Commitment
John Rim, the CEO and President of Samsung Biologics, articulated the healthcare sector's pivotal role in carbon emissions. He stressed the company's commitment to responsible practices, stating, "It is our responsibility to be at the forefront of efforts to promote sustainable value chains." Samsung Biologics is dedicated to supporting suppliers in enhancing their ESG management efforts and steering towards a greener future.
Striving for Net Zero by 2050
Samsung Biologics has laid out ambitious goals, aiming for net-zero carbon emissions by 2050. This resolve is fortified by sustainable operations that utilize low-carbon technologies, such as ultra-low NOx boilers and energy monitoring systems. Furthermore, the company has begun transitioning to renewable energy, including the installation of onsite solar panels. Recognizing these efforts, Samsung Biologics has been honored with a Terra Carta Seal—a testament to its alignment with sustainable practices as well as an EcoVadis platinum rating.
Collaboration with Global Pharmaceutical Partners
To achieve these goals, Samsung Biologics is actively engaging with global pharmaceutical companies. Working as a champion in the Supply Chains Working Group within the Sustainable Markets Initiative (SMI), the company is leading efforts to decarbonize healthcare and build more resilient value chains.
Supplier Responsibilities in Sustainable Practices
During the Supplier ESG Day, Samsung Biologics encouraged its suppliers to actively participate in enhancing the sustainability of global value chains. Suppliers were urged to stay updated with international reporting standards, such as the European Union Corporate Sustainability Due Diligence Directive and International Financial Reporting Standards. This proactive approach ensures that all players in the supply chain remain accountable for their environmental impact.
Expert Insights Provided at the Event
The event also featured insights from external ESG specialists who highlighted various ESG-related requirements. They provided valuable information on sustainability reports and disclosed tools specifically tailored for small and mid-sized companies, ensuring that suppliers can adequately address ESG criteria.
About Samsung Biologics
Samsung Biologics (KRX: 207940.KS) is an end-to-end contract development and manufacturing organization (CDMO) catering to the biopharmaceutical sector. The company provides a comprehensive range of services, from cell line development to aseptic fill/finish. Their state-of-the-art facilities comply with CGMP standards and offer bioreactor capacities tailored to diverse client needs. With the completion of Bio Campus I and the upcoming Plant 5 construction under Bio Campus II, Samsung Biologics aims to meet the rising demand for biomanufacturing.
Contact Information
For more information, reach out to Claire Kim, Head of Global Marketing Communication at Samsung Biologics.
Frequently Asked Questions
What is the purpose of the Supplier ESG Day?
The Supplier ESG Day is designed to enhance collaboration among suppliers regarding sustainable practices and ESG management.
How many companies participated in the event?
Over 82 suppliers participated in the virtual event, including leading companies in the biopharmaceutical sector.
What are Samsung Biologics' sustainability goals?
Samsung Biologics aims to achieve net zero emissions by 2050, utilizing low-carbon technologies and renewable energy sources.
Who spoke at the event?
John Rim, the CEO and President of Samsung Biologics, along with external ESG specialists who provided insights on sustainability compliance.
What recognition has Samsung Biologics received for its efforts?
The company has received the Terra Carta Seal and an EcoVadis platinum rating for its commitment to sustainable practices.
